Your browser is no longer supported. Please, upgrade your browser.
Settings
VCEL Vericel Corporation daily Stock Chart
VCEL [NASD]
Vericel Corporation
Index- P/E- EPS (ttm)-1.09 Insider Own9.31% Shs Outstand31.74M Perf Week8.79%
Market Cap157.11M Forward P/E- EPS next Y-0.37 Insider Trans0.00% Shs Float29.77M Perf Month43.48%
Income-29.00M PEG- EPS next Q-0.16 Inst Own34.90% Short Float5.19% Perf Quarter65.00%
Sales53.80M P/S2.92 EPS this Y-21.00% Inst Trans6.25% Short Ratio2.92 Perf Half Y73.68%
Book/sh0.43 P/B11.51 EPS next Y41.30% ROA-75.30% Target Price6.59 Perf Year87.50%
Cash/sh0.44 P/C11.22 EPS next 5Y- ROE807.20% 52W Range2.00 - 5.25 Perf YTD65.00%
Dividend- P/FCF- EPS past 5Y35.10% ROI534.60% 52W High-5.71% Beta3.07
Dividend %- Quick Ratio2.30 Sales past 5Y396.60% Gross Margin45.60% 52W Low147.50% ATR0.24
Employees202 Current Ratio2.60 Sales Q/Q32.80% Oper. Margin-45.30% RSI (14)77.95 Volatility5.90% 6.23%
OptionableYes Debt/Eq0.73 EPS Q/Q66.30% Profit Margin-53.90% Rel Volume0.60 Prev Close4.95
ShortableYes LT Debt/Eq0.58 EarningsAug 09 BMO Payout- Avg Volume529.80K Price4.95
Recom1.50 SMA2014.12% SMA5032.94% SMA20062.06% Volume317,659 Change0.00%
Jun-21-17Initiated BTIG Research Buy $6
Mar-13-17Reiterated Needham Buy $9 → $6
Dec-22-16Initiated Piper Jaffray Overweight $6
Nov-09-16Reiterated Needham Buy $12 → $9
Apr-05-16Downgrade BofA/Merrill Buy → Neutral
Mar-11-16Upgrade Needham Hold → Buy $12
Sep-22-17 11:20AM  ETFs with exposure to Vericel Corp. : September 22, 2017 Capital Cube
Sep-20-17 11:30AM  Vericel Corp. :VCEL-US: Earnings Analysis: Q2, 2017 By the Numbers : September 20, 2017 Capital Cube
08:00AM  Vericel to Present at the Ladenburg Thalmann 2017 Healthcare Conference GlobeNewswire
Aug-13-17 12:30PM  Edited Transcript of VCEL earnings conference call or presentation 9-Aug-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-09-17 07:00AM  Vericel Reports Second-Quarter 2017 Financial Results GlobeNewswire +13.33%
05:00AM  Investor Network: Vericel Corporation to Host Earnings Call ACCESSWIRE
Jul-26-17 08:00AM  Vericel to Host Second-Quarter 2017 Earnings Webcast and Conference Call on August 9, 2017 GlobeNewswire
Jul-13-17 08:00AM  Vericel to Host Symposium on MACI Implant for Treating Articular Cartilage Defects in the Knee at AOSSM 2017 Annual Meeting GlobeNewswire
Jul-07-17 03:38PM  ETFs with exposure to Vericel Corp. : July 7, 2017 Capital Cube
Jun-26-17 05:09PM  ETFs with exposure to Vericel Corp. : June 26, 2017 Capital Cube +6.67%
Jun-16-17 04:25PM  ETFs with exposure to Vericel Corp. : June 16, 2017 Capital Cube
Jun-14-17 09:44AM  Vericel Corp. :VCEL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
May-18-17 01:01PM  Edited Transcript of VCEL earnings conference call or presentation 10-May-17 12:00pm GMT Thomson Reuters StreetEvents
May-12-17 11:15AM  Edited Transcript of VCEL earnings conference call or presentation 10-May-17 12:00pm GMT Thomson Reuters StreetEvents
May-10-17 07:00AM  Vericel Reports First-Quarter 2017 Financial Results GlobeNewswire
07:00AM  Vericel Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Ixmyelocel-T for the Treatment of Advanced Heart Failure Due to Ischemic Dilated Cardiomyopathy GlobeNewswire
07:00AM  Vericel Licenses Product Portfolio to Innovative Cellular Therapeutics for Distribution in China, South Korea, and other Countries in Southeast Asia GlobeNewswire
07:00AM  Investor Network: Vericel Corporation to Host Earnings Call Accesswire
May-04-17 03:21PM  Vericel to Host First-Quarter 2017 Earnings Webcast and Conference Call on May 10, 2017 GlobeNewswire
Apr-20-17 11:03AM  Vericel to Present at the 5th Annual Cell & Gene Therapy Investor Day GlobeNewswire
Apr-07-17 05:41PM  ETFs with exposure to Vericel Corp. : April 7, 2017 Capital Cube
Mar-28-17 08:00AM  Vericel to Present at the 16th Annual Needham Healthcare Conference GlobeNewswire
Mar-27-17 04:09PM  ETFs with exposure to Vericel Corp. : March 27, 2017 Capital Cube
04:09PM  ETFs with exposure to Vericel Corp. : March 27, 2017
Mar-23-17 10:15AM  Outcomes Data From Over 950 Severe Burn Patients Treated With Epicel Presented at the 49th Annual Meeting of the American Burn Association GlobeNewswire
Mar-21-17 11:32AM  Vericel Corp. :VCEL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Capital Cube -5.17%
11:32AM  Vericel Corp. :VCEL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
09:55AM  Vericel Corp. :VCEL-US: Earnings Analysis: 2016 By the Numbers : March 21, 2017
Mar-16-17 01:04PM  VERICEL CORP Financials
Mar-13-17 08:33AM  VERICEL CORP Files SEC form 10-K, Annual Report
Mar-10-17 08:10AM  VERICEL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:15AM  Vericel Reports Fourth-Quarter and Year-End 2016 Financial Results GlobeNewswire
Mar-03-17 07:30AM  Vericel to Host Fourth-Quarter 2016 Earnings Webcast and Conference Call on March 10, 2017 GlobeNewswire
Feb-27-17 04:30PM  Vericel to Present at Multiple Upcoming Investor Conferences GlobeNewswire
Feb-23-17 10:07AM  Why President Trump Wants To Transform The FDA And What It Could Mean For Biotech Stocks Insider Monkey
10:07AM  Why President Trump Wants To Transform The FDA And What It Could Mean For Biotech Stocks at Insider Monkey
Feb-21-17 07:30AM  Vericel Receives FDA Fast Track Designation for Ixmyelocel-T, an Investigational Product for the Treatment of Patients with Advanced Heart Failure Due to Ischemic Dilated Cardiomyopathy GlobeNewswire
Feb-01-17 07:00AM  Vericel Announces First MACI Implant in the United States for the Treatment of Symptomatic Cartilage Defects of the Knee GlobeNewswire
Jan-19-17 02:07PM  ETFs with exposure to Vericel Corp. : January 19, 2017
Dec-30-16 04:10PM  VERICEL CORP Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Dec-29-16 02:48PM  ETFs with exposure to Vericel Corp. : December 29, 2016
Dec-22-16 08:22AM  Coverage initiated on Vericel by Piper Jaffray
Dec-21-16 04:05PM  Vericel Corporation Announces Exercise of Underwriters Over-Allotment Option and Closing of $20 Million Offering of Common Stock GlobeNewswire
Dec-17-16 03:47PM  Is Rentech, Inc. (RTK) A Good Stock To Buy According To Hedge Funds? at Insider Monkey
Dec-16-16 05:31PM  VERICEL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement -12.86%
12:27PM  ETFs with exposure to Vericel Corp. : December 16, 2016
09:14AM  Vericel Corporation Prices $17 Million Public Offering of Common Stock GlobeNewswire
Dec-15-16 06:12PM  Vericel Corporation Announces Proposed Public Offering of Common Stock GlobeNewswire -14.63%
Dec-14-16 12:12PM  VERICEL CORP Files SEC form 8-K, Other Events +57.69%
08:40AM  Vericel Wins on Key FDA Approval
08:27AM  Vericel's stock soars in premarket-leading volume after FDA approval of cartilage repair product at MarketWatch
07:10AM  FDA Approves MACI for the Treatment of Symptomatic Cartilage Defects of the Knee in Adults GlobeNewswire
Dec-13-16 09:20PM  FDA approves Cambridge-based Vericel's knee cartilage repair product at bizjournals.com
Dec-08-16 11:45AM  All Eyes on These Two Biotech Firms Ahead of FDA Decisions (VCEL, SGYP) at Investopedia
Nov-29-16 02:07PM  VERICEL CORP Files SEC form 8-K, Unregistered Sale of Equity Securities
Nov-25-16 06:02AM  VERICEL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-22-16 08:30AM  Vericel to Present at 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-17-16 04:19PM  VERICEL CORP Files SEC form 8-K, Regulation FD Disclosure, Other Events
Nov-14-16 02:36PM  ETFs with exposure to Vericel Corp. : November 14, 2016
02:00PM  Additional Pre-Specified Secondary Results on the Reduction of Ventricular Arrhythmias Presented at AHA from Vericels Positive Phase 2b ixCELLDCM Clinical Trial of Ixmyelocel-T GlobeNewswire
Nov-10-16 10:40AM  3 Attractive Biotech Stocks With Upcoming Catalysts (VCEL, DVAX) at Investopedia +12.20%
Nov-09-16 12:03PM  Vericel Corp. :VCEL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016
Nov-07-16 04:36PM  VERICEL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Vericel Reports Third-Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q3 2016 Vericel Corp Earnings Release - Time Not Supplied
Nov-01-16 12:38PM  ETFs with exposure to Vericel Corp. : November 1, 2016
Oct-31-16 08:00AM  Vericel to Host Third-Quarter 2016 Earnings Webcast and Conference Call on November 7, 2016 GlobeNewswire -6.38%
Oct-12-16 03:45PM  Biotech Movers And Shakers: Vericel Corp (VCEL) and Illumina, Inc. (ILMN) at Insider Monkey
Oct-11-16 06:09AM  VERICEL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -14.95%
Sep-26-16 08:00AM  Vericel to Present at 2016 Cell & Gene Meeting on the Mesa GlobeNewswire -5.14%
Sep-21-16 08:00AM  Vericel to Present at Ladenburg Thalmann Healthcare Conference GlobeNewswire
Sep-14-16 04:32PM  VERICEL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agr
Sep-12-16 08:00AM  Vericel Enters into Expanded $20 Million Credit Facility and Term Loan with Silicon Valley Bank and MidCap Financial Services GlobeNewswire +5.45%
Sep-09-16 11:32AM  ETFs with exposure to Vericel Corp. : September 9, 2016
Sep-07-16 08:00AM  Vericel to Present Data at the American Heart Associations Scientific Sessions 2016 on the Reduction of Ventricular Arrhythmias with Ixmyelocel-T in the ixCELL-DCM Clinical Trial GlobeNewswire
Aug-25-16 10:33AM  ETFs with exposure to Vericel Corp. : August 25, 2016
Aug-12-16 02:48PM  ETFs with exposure to Vericel Corp. : August 12, 2016
Aug-11-16 11:19AM  Vericel Corp. :VCEL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-08-16 04:12PM  VERICEL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Vericel Reports Second-Quarter 2016 Financial Results GlobeNewswire
Aug-01-16 07:30AM  Vericel to Host Second-Quarter 2016 Earnings Webcast and Conference Call on August 8, 2016 GlobeNewswire
Jul-19-16 01:19PM  ETFs with exposure to Vericel Corp. : July 19, 2016
Jul-06-16 04:30PM  Vericel to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference GlobeNewswire
Jun-23-16 08:00AM  Momenta Pharmaceuticals Appoints Steven C. Gilman, Ph.D. to Board of Directors GlobeNewswire
Jun-03-16 09:08AM  Biotech Industrys Stocks Get Research Review
May-23-16 12:59PM  Vericel Corp. :VCEL-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
May-10-16 07:47AM  VERICEL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +10.41%
07:30AM  Vericel Reports First-Quarter 2016 Financial Results GlobeNewswire
May-06-16 04:17PM  VERICEL CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Apr-27-16 04:30PM  Vericel to Host First-Quarter 2016 Earnings Webcast and Conference Call on May 10, 2016 GlobeNewswire
Apr-26-16 04:37PM  VERICEL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
Apr-11-16 05:09PM  VERICEL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
Apr-08-16 08:30AM  Vericel to Present at 15th Annual Needham Healthcare Conference GlobeNewswire
Apr-04-16 02:25PM  Last months big stock spike at Vericel cut in half by further trial data at bizjournals.com -38.31%
12:10PM  VERICEL CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
11:45AM  Vericel stem cell therapy cuts heart failure death, hospitalization-study
11:45AM  Results from Vericels Positive Phase 2b ixCELL-DCM Clinical Trial of Ixmyelocel-T Presented Today at ACC and Published in The Lancet GlobeNewswire
Apr-01-16 08:30AM  Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors GlobeNewswire
Mar-29-16 08:37AM  Vericel to Host Review of Positive Phase 2b ixCELL-DCM Trial Results Following American College of Cardiology 65th Annual Scientific Sessions at noodls +11.40%
08:30AM  Vericel to Host Review of Positive Phase 2b ixCELL-DCM Trial Results Following American College of Cardiology 65th Annual Scientific Sessions GlobeNewswire
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, markets, and sells patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. It markets three autologous cell therapy products, including Carticel and MACI, which are used for the treatment of cartilage defects in the knee; and Epicel, a permanent skin replacement that is used for the treatment of patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area in the United States. The company also develops ixmyelocel-T, which is in Phase IIb clinical trial, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was founded in 1989 and is headquartered in Cambridge, Massachusetts.